Goldman Sachs has closed a $650 million fund focused on biotech investments, making it one of the largest first-time private life sciences growth funds. The West Street Life Sciences I fund will be managed by Goldman Sachs Asset Management’s Life Sciences Investing Group and will target early to mid-stage therapeutic companies, as well as life sciences tools and diagnostics companies. The fund has already allocated $90 million to five companies in its portfolio. Goldman Sachs highlighted several themes of fundamental innovation, including precision medicine, genetic medicine, cell therapy, immunotherapy, synthetic biology, and artificial intelligence, as drivers of future growth in the life sciences sector. Despite declining fundraises for biopharma, Goldman Sachs’ $650 million fund offers reassurance to the industry.
Goldman Sachs seals $650M biotech fund—unveiling an alluring investment prospect!
Latest from Blog
Birdnest: Egyptian Startup Secures Pre-Series A Funding for Proptech
TLDR: Egyptian proptech startup Birdnest secured pre-Series A funding from Beltone Venture Capital and CI Venture Capital. The funding amount remains undisclosed but is exchanged for a 20 percent stake in the
Empowering Europe’s LGBTQ+ startups: Identityvc’s capital and community
TLDR: TechCrunch is part of the Yahoo family of brands. When using their sites and apps, they use cookies for various purposes. In a recent article, TechCrunch, a member of the Yahoo
NAB Ventures on the Hunt for Fresh Investments Amid Model Evolution
TLDR: NAB Ventures is actively looking for new investments in the market for startups and fintechs. NAB Ventures remains committed to its original label and strategy while other bank VC funds have
Israel: A Lucrative Investment Opportunity Amid Middle East Conflicts
TLDR: A new investment club named “Eretz Angels” has been launched to support deep-tech technological ventures in Israel’s northern and southern communities. The club aims to breathe new life into struggling areas
DeSantis and GOP Sabotage Diversity, Equity, and Inclusion Efforts
TLDR: A three-member panel ruled that the Fearless Fund violated the Civil Rights Act by awarding grants to Black women Less than 1% of venture capital goes to Black and Hispanic women-owned